Accelerometer data from over 85,000 UK Biobank participants reveal significant sex differences in physical activity benefits for heart disease prevention and survival.
Patients with type 2 diabetes who developed urinary tract infections while taking sodium-glucose cotransporter-2 inhibitors faced higher heart and kidney risks.